The 7th Annual International Conference „Good Distribution Practise, Cooperation and Partnership“...

Rhei Life is pleased to announce that as of April 1st 2022, Olivera Kravic has joined our team

In 2021, Rhei Life demonstrated great strength in a challenging market environment, generating growth across all divisions.

Two products from our CHC portflio will be launched in H2 2022. in Myanmar due to signed partnership with company Healthy Max…

Along with our partners, we have extended the contract for BCG vaccine supply with the Croatian Institute for Public Health for an…

A new agreement has been signed and a new partnership confirmed with one of the most innovative Indian pharmaceutical companies.

Selma Alić has joined Rhei Life as Regulatory Affairs Associate, with 7-year experience in RA and other different pharmaceutical fields. She holds…

Tigecycline is used to treat certain serious bacterial infections when other antibiotics may not work. It is related to a class of…

We successfully imported Liposomal Amphotericin B injection, as a non-registered medicine, to several markets in the Balkan region (Serbia, Bosnia and Herzegovina,…

Our partner Amsal in Bosnia launched Memoxa 5mg (Vinpocetine) sucesfully, after more than a year of sucesful sales and marketing results with…